BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16563910)

  • 1. Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation.
    Detaint D; Messika-Zeitoun D; Chen HH; Rossi A; Avierinos JF; Scott C; Burnett JC; Enriquez-Sarano M
    Am J Cardiol; 2006 Apr; 97(7):1029-34. PubMed ID: 16563910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome.
    Detaint D; Messika-Zeitoun D; Avierinos JF; Scott C; Chen H; Burnett JC; Enriquez-Sarano M
    Circulation; 2005 May; 111(18):2391-7. PubMed ID: 15883225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
    Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
    Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure.
    Lancellotti P; Cosyns B; Piérard LA
    Europace; 2008 Apr; 10(4):496-501. PubMed ID: 18319268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation.
    Mayer SA; De Lemos JA; Murphy SA; Brooks S; Roberts BJ; Grayburn PA
    Am J Cardiol; 2004 Apr; 93(8):1002-6. PubMed ID: 15081443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy.
    Kainuma S; Taniguchi K; Toda K; Shudo Y; Takeda K; Funatsu T; Miyagawa S; Kondoh H; Nishi H; Yoshikawa Y; Fukushima S; Hamada S; Kubo K; Daimon T; Sawa Y
    J Cardiol; 2015 Oct; 66(4):279-85. PubMed ID: 25851471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation.
    Kerr AJ; Raffel OC; Whalley GA; Zeng I; Stewart RA
    Eur Heart J; 2008 Feb; 29(3):363-70. PubMed ID: 18202251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
    Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular reverse remodeling early after mitral valve repair for severe chronic mitral regurgitation with atrial fibrillation.
    Song BG; On YK; Jeon ES; Park JH; Choi JO; Lee SC; Park SW; Kim JS; Park PW
    Cardiology; 2009; 114(2):132-41. PubMed ID: 19521078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No change in B-type natriuretic peptide levels assessed in the late postoperative period in patients with severe mitral regurgitation after mitral valve surgery.
    Krishnaswami A; Jang JJ; Berkheimer S; Pompili M; Lee H
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):768-71. PubMed ID: 21343155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of the myocardial performance index with plasma B-type natriuretic peptide levels in patients with mitral regurgitation.
    Sayar N; Lütfullah Orhan A; Cakmak N; Yilmaz H; Atmaca H; Tangürek B; Hasdemir H; Nurkalem Z; Ergelen M; Aksu H; Yeşilçimen K
    Int J Cardiovasc Imaging; 2008 Feb; 24(2):151-7. PubMed ID: 17541723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the tissue Doppler-derived Tei index and plasma brain natriuretic peptide levels in patients with mitral regurgitation.
    Kargin R; Esen O; Akçakoyun M; Pala S; Candan O; Omaygenç MO; Dogan C; Barutçu I; Esen AM; Ozdemir N
    J Heart Valve Dis; 2010 Jan; 19(1):35-42. PubMed ID: 20329488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy.
    De Bonis M; Lapenna E; Verzini A; La Canna G; Grimaldi A; Torracca L; Maisano F; Alfieri O
    Ann Thorac Surg; 2008 Mar; 85(3):932-9. PubMed ID: 18291174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation.
    Sitges M; Vidal B; Delgado V; Mont L; Garcia-Alvarez A; Tolosana JM; Castel A; Berruezo A; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Aug; 104(3):383-8. PubMed ID: 19616672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of B-type natriuretic peptide early after acute myocardial infarction to left ventricular diastolic function and extent of myocardial damage determined by magnetic resonance imaging.
    Paelinck BP; Vrints CJ; Bax JJ; Bosmans JM; De Hert SG; de Roos A; Lamb HJ
    Am J Cardiol; 2006 Apr; 97(8):1146-50. PubMed ID: 16616016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.